No record of blood clot linked to COVID-19 vaccinations in Ghana– FDA
The Food and Drugs Authority (FDA) says Ghana has not recorded any blood clot case linked to the COVID-19 vaccinations in the country.
According to FDA, so far the side effects monitored were headaches, fever, chills, body pains, pain at injection site, weakness, nausea and dizziness.
The FDA, therefore, re-assured the public that it is closely monitoring the situation locally and to date no events of blood clots linked to the Covishield vaccines have been reported among those who have been vaccinated in Ghana.
This was contained in a press release issued and signed by the Chief Executive Officer of the Food and Drugs Authority (FDA), Mrs Delese Darko.
She said in February 2021, the FDA constituted a committee of experts, the Joint COVID-19 Vaccine Safety Review Committee (JCVSRC),which met bi-weekly to assess all reported adverse events and make recommendations on the safety of the COVID-19 vaccines.
“Generally, vaccines and medicines tend to have some side effects and this needs to be continually balanced against the expected benefits in preventing illnesses,” she added.
Mrs Darko said the Authority would continue to work with experts and other regulators globally and would use its established safety monitoring system to support the vaccine programme to ensure public health safety.